Report for Egoz I

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : Ocular surface histopathological insult following sarin and VX exposure and potential treatments in the rat model - Gore_2019_Toxicol.Lett_314_153
Author(s) : Gore A , Lazar S , Yacov G , Gez R , Rabinowitz I , Nili U , Egoz I , Kadar T
Ref : Toxicol Lett , 314 :153 , 2019
Abstract : Gore_2019_Toxicol.Lett_314_153
ESTHER : Gore_2019_Toxicol.Lett_314_153
PubMedSearch : Gore_2019_Toxicol.Lett_314_153
PubMedID: 31408696

Title : Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats - Bloch-Shilderman_2019_Arch.Toxicol_93_1365
Author(s) : Bloch-Shilderman E , Yacov G , Cohen L , Egoz I , Gutman H , Gez R , Rabinovitz I , Nili U
Ref : Archives of Toxicology , 93 :1365 , 2019
Abstract : Bloch-Shilderman_2019_Arch.Toxicol_93_1365
ESTHER : Bloch-Shilderman_2019_Arch.Toxicol_93_1365
PubMedSearch : Bloch-Shilderman_2019_Arch.Toxicol_93_1365
PubMedID: 30729277

Title : Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats - Bloch-Shilderman_2018_Arch.Toxicol_92_873
Author(s) : Bloch-Shilderman E , Rabinovitz I , Egoz I , Yacov G , Allon N , Nili U
Ref : Archives of Toxicology , 92 :873 , 2018
Abstract : Bloch-Shilderman_2018_Arch.Toxicol_92_873
ESTHER : Bloch-Shilderman_2018_Arch.Toxicol_92_873
PubMedSearch : Bloch-Shilderman_2018_Arch.Toxicol_92_873
PubMedID: 29127449

Title : Optimization of the Ocular Treatment Following Organophosphate Nerve Agent Insult - Egoz_2017_Toxicol.Sci_159_50
Author(s) : Egoz I , Nili U , Grauer E , Gore A
Ref : Toxicol Sci , 159 :50 , 2017
Abstract : Egoz_2017_Toxicol.Sci_159_50
ESTHER : Egoz_2017_Toxicol.Sci_159_50
PubMedSearch : Egoz_2017_Toxicol.Sci_159_50
PubMedID: 28903494

Title : Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes - Lazar_2016_Toxicol.Appl.Pharmacol_310_87
Author(s) : Lazar S , Egoz I , Brandeis R , Chapman S , Bloch-Shilderman E , Grauer E
Ref : Toxicol Appl Pharmacol , 310 :87 , 2016
Abstract : Lazar_2016_Toxicol.Appl.Pharmacol_310_87
ESTHER : Lazar_2016_Toxicol.Appl.Pharmacol_310_87
PubMedSearch : Lazar_2016_Toxicol.Appl.Pharmacol_310_87
PubMedID: 27639427

Title : Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats - Gore_2014_Br.J.Pharmacol_171_2364
Author(s) : Gore A , Bloch-Shilderman E , Egoz I , Turetz J , Brandeis R
Ref : British Journal of Pharmacology , 171 :2364 , 2014
Abstract : Gore_2014_Br.J.Pharmacol_171_2364
ESTHER : Gore_2014_Br.J.Pharmacol_171_2364
PubMedSearch : Gore_2014_Br.J.Pharmacol_171_2364
PubMedID: 24428128

Title : Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity - Katalan_2013_Arch.Toxicol_87_347
Author(s) : Katalan S , Lazar S , Brandeis R , Rabinovitz I , Egoz I , Grauer E , Bloch-Shilderman E , Raveh L
Ref : Archives of Toxicology , 87 :347 , 2013
Abstract : Katalan_2013_Arch.Toxicol_87_347
ESTHER : Katalan_2013_Arch.Toxicol_87_347
PubMedSearch : Katalan_2013_Arch.Toxicol_87_347
PubMedID: 23052190

Title : Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats - Gore_2012_Toxicol.Sci_126_515
Author(s) : Gore A , Brandeis R , Egoz I , Peri D , Turetz J , Bloch-Shilderman E
Ref : Toxicol Sci , 126 :515 , 2012
Abstract : Gore_2012_Toxicol.Sci_126_515
ESTHER : Gore_2012_Toxicol.Sci_126_515
PubMedSearch : Gore_2012_Toxicol.Sci_126_515
PubMedID: 22247005

Title : Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen - Raveh_2008_Toxicol.Appl.Pharmacol_227_155
Author(s) : Raveh L , Rabinovitz I , Gilat E , Egoz I , Kapon J , Stavitsky Z , Weissman BA , Brandeis R
Ref : Toxicol Appl Pharmacol , 227 :155 , 2008
Abstract : Raveh_2008_Toxicol.Appl.Pharmacol_227_155
ESTHER : Raveh_2008_Toxicol.Appl.Pharmacol_227_155
PubMedSearch : Raveh_2008_Toxicol.Appl.Pharmacol_227_155
PubMedID: 18320638

Title : Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies - Bloch-Shilderman_2008_Toxicol.Appl.Pharmacol_231_17
Author(s) : Bloch-Shilderman E , Rabinovitz I , Egoz I , Raveh L , Allon N , Grauer E , Gilat E , Weissman BA
Ref : Toxicol Appl Pharmacol , 231 :17 , 2008
Abstract : Bloch-Shilderman_2008_Toxicol.Appl.Pharmacol_231_17
ESTHER : Bloch-Shilderman_2008_Toxicol.Appl.Pharmacol_231_17
PubMedSearch : Bloch-Shilderman_2008_Toxicol.Appl.Pharmacol_231_17
PubMedID: 18485435